UnitedHealth Group (NYSE:UNH) Shares Gap Up on Analyst Upgrade

UnitedHealth Group Incorporated (NYSE:UNH) gapped up prior to trading on Tuesday after Sanford C. Bernstein raised their price target on the stock from $405.00 to $411.00. The stock had previously closed at $281.36, but opened at $308.85. Sanford C. Bernstein currently has an outperform rating on the stock. UnitedHealth Group shares last traded at $304.0070, with a volume of 6,970,907 shares changing hands.

UNH has been the subject of several other research reports. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $300.00 price objective for the company in a report on Tuesday. KeyCorp reiterated an “overweight” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. Barclays reduced their price target on UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating for the company in a report on Friday, January 30th. UBS Group reduced their price target on UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating for the company in a report on Wednesday, January 28th. Finally, Royal Bank Of Canada reduced their price target on UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. One analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, eight have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average price target of $363.42.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: CMS raised 2027 Medicare Advantage payments by ~2.48%, a surprise above street expectations — this directly improves UnitedHealth’s revenue and margin outlook for Medicare Advantage and triggered a broad relief rally across managed-care names. UnitedHealth Rockets 11%, Humana Climbs 9% as Medicare Advantage Rate Decision Crushes Regulatory Fears
• Positive Sentiment: Several sell-side analysts raised price targets and upgraded UNH after the CMS decision (example: BofA and Sanford C. Bernstein moves), contributing to the near-term re-rating and higher trading volume. UnitedHealth Price Target Raised to $337 by BofA After Medicare Advantage Rate Finalization
• Positive Sentiment: Street research and note-writers are quantifying meaningful upside from the CMS move (several pieces estimate billions in incremental revenue/operating profit and reduced downside risk), which supports expectations for margin recovery driven by UnitedHealth’s scale and Optum capabilities. UnitedHealth Could Reprice Soon: The Catalyst Is Here
• Neutral Sentiment: Wall Street remains broadly constructive on UNH: ~75% of covering analysts rate the stock bullishly with a consensus target around $355, and UNH is highlighted among hedge-fund favorites — that supports medium-term investor interest but already implies some upside is priced in. Analysts Remain Confident in UnitedHealth (UNH)’s Growth Initiatives Outside of Its Main Insurance Operations
• Neutral Sentiment: Recent fundamental context: UnitedHealth beat Q4/most-recent EPS estimates and provided FY-level guidance, which underpinned confidence before the CMS news — but consensus EPS forecasts remain materially higher than some boutique analyst raises. UnitedHealth Stock Jumps on Better-Than-Expected Medicare Advantage Rates. Here’s Why the Rally Might Be Short-Lived
• Negative Sentiment: Caution: commentators warn the Medicare tailwind may be partially priced in after the large one-day rally and the stock faces near-term catalysts (upcoming quarterly results) that could reintroduce volatility if guidance or cost trends disappoint. UnitedHealth Stock Jumps on Better-Than-Expected Medicare Advantage Rates. Here’s Why the Rally Might Be Short-Lived
• Negative Sentiment: Macroeconomic and cost risks remain (medical-cost inflation, optical/claims mix, and broader interest-rate/market moves). Those factors plus profit-taking after the run-up explain why UNH has pulled back from its intraday highs. UnitedHealth (UNH) Soars 9.4%: Is Further Upside Left in the Stock?

Institutional Investors Weigh In On UnitedHealth Group

Several hedge funds have recently bought and sold shares of UNH. Sarver Vrooman Wealth Advisors acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. Beacon Financial Strategies CORP acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. Anfield Capital Management LLC raised its position in shares of UnitedHealth Group by 220.0% in the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after buying an additional 55 shares in the last quarter. Joseph Group Capital Management acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $27,000. Finally, Nalls Sherbakoff Group LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $27,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 0.5%

The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79. The business’s 50-day moving average price is $282.36 and its two-hundred day moving average price is $318.95. The company has a market capitalization of $278.02 billion, a price-to-earnings ratio of 23.22, a P/E/G ratio of 1.28 and a beta of 0.40.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. The business had revenue of $113.73 billion for the quarter, compared to analysts’ expectations of $113.38 billion. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The firm’s quarterly revenue was up 12.3% compared to the same quarter last year. During the same period last year, the firm posted $6.81 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend was Monday, March 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 67.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.